Showing 2401-2410 of 3039 results for "".
- CooperVision Seeks Proposals for 2023 Science and Technology Awardshttps://modernod.com/news/coopervision-seeks-proposals-for-2023-science-and-technology-awards/2481549/CooperVision announced it is now accepting submissions for its 2023 Science and Technology Awards program. The program enables researchers around the world to explore new dimensions in vision care, with the goal of translating innovative ideas into practical solutions. Each year, Cooper
- Haag-Streit Launches New EyeSuite Softwarehttps://modernod.com/news/haag-streit-launches-new-eyesuite-software/2481532/Haag-Streit has announced the launch of EyeSuite software version i9.13, which offers new features for the Eyestar 900’s Anterior Chamber Suite and market-first functionality for the Lenstar Myopia. In addition, it’s existing portfolio of I
- Ocutrx Technologies Acquires Circuit Board Manufacturing Company Spectrum Advanced Manufacturing Technologieshttps://modernod.com/news/ocutrx-technologies-acquires-circuit-board-manufacturing-company-spectrum-advanced-manufacturing-technologies/2481531/Ocutrx Technologies announced it has acquired Spectrum Advanced Manufacturing Technologies, a Colorado-based electronics manufacturing and assembly company. Terms of the deal were not disclosed. With this acquisition, the consolidated Oxutrx_Spectrum company now
- Radius Announces Software Upgrade for Wearable Device for Perimetric Examinationshttps://modernod.com/news/radius-announces-perimeter-software-upgrade-for-wearable-device/2481518/Radius XR has launched its Radius 1.0 software release for perimetric examinations. Its interface is designed to assist eye care practices in delivering more comprehensive glaucoma management. Radius is a portable Vision Diagnostic and Patient Engagement system that combi
- EverSight Launches Preloaded DMEK EndoGlidehttps://modernod.com/news/eversight-launches-preloaded-dmek-endoglide-1/2481517/Nonprofit eye bank Eversight announced the availability of Descemet’s membrane endothelial keratoplasty (DMEK) tissue preloaded in EndoGlide, offering corneal surgeons a fourth preloaded DMEK option to further s
- World Council of Optometry and Alcon to Launch “WCO Alcon Dry Eye Wheel” Tool for Dry Eye Diseasehttps://modernod.com/news/world-council-of-optometry-and-alcon-to-launch-wco-alcon-dry-eye-wheel-tool-for-dry-eye-disease/2481496/The World Council of Optometry (WCO) and Alcon invite eye care professionals worldwide to the launch of a new tool to help with the diagnosis and treatment of dry eye disease. Registration is now open for the May 9 “Dry Eye Spotlight 4: WCO Alcon Dry Eye Wheel” webinar, the
- Study: Reduced Oxygen Transport to the Retina Contributing to Damage to the Fine Blood Vessels Causes Diabetic Retinopathyhttps://modernod.com/news/study-reduced-oxygen-transport-to-the-retina-owing-to-damage-to-the-fine-blood-vessels-causes-diabetic-retinopathy/2481492/Researchers in Austria have now found evidence for a previously suspected connection: reduced oxygen transport to the retina contributes to damage to the fine blood vessels, causing diabetic retinopathy. A common complication of diabetes, this retinal damage can ultimately lead to blind
- International Sports Vision Association Announces Leadership Appointments OF NEW EXECUTIVE AND ADVISORY BOARD OFFICERShttps://modernod.com/news/international-sports-vision-association-announces-leadership-appointments-of-new-executive-and-advisory-board-officers/2481491/The International Sports Vision Association (ISVA) announced the appointments of its new Executive and Advisory Board members, effective April 1, 2023. Executive Board Alireza Somji, OD assumes the position of President, succeeding Charles Shidlofsky, OD, FCOV
- Aurion Biotech Receives Approval in Japan for First Allogeneic Cell Therapy to Treat Corneal Endothelial Diseasehttps://modernod.com/news/aurion-biotech-receives-approval-in-japan-for-first-allogeneic-cell-therapy-to-treat-corneal-endothelial-disease/2481486/Aurion Biotech announced it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its novel cell therapy, Vyznova, for the treatment of bullous keratopathy of the cornea. The company believes this is the first regulatory approval in the world fo
- The American Diabetes Association and Genentech Partner to Increase Equitable Access to Eye Health Carehttps://modernod.com/news/the-american-diabetes-association-and-genentech-partner-to-increase-equitable-access-to-eye-health-care/2481482/The American Diabetes Association (ADA) and Genentech announced a new partnership as part of the ADA’s Health Equity Now work to tackle access to screening and treatment for eye diseases that affect the diabetes communit